House Democrat Calls Congress ‘The Poster Child for Cowardice” on ISIS

Amid growing signs that the U.S. faces nothing but bad choices in its war against ISIS, Rep. Jim McGovern, a liberal Democrat from Massachusetts, today denounced Congress as “the poster child for cowardice” for refusing to debate a new war powers resolution to set parameters for the Obama administration’s efforts to “degrade and defeat” the jihadist terrorists in Iraq and Syria.
At the behest of Republican and Democratic leaders, Obama sent a proposed war powers resolution to Congress in February outlining his core objectives of systematically destroying the jihadist terror group through a sustained campaign of airstrikes, supporting and training allied forces on the ground and humanitarian assistance – but without committing a large number of U.S. combat troops to the effort.
Related: U.S. Shoots Itself in the Foot By Accidentally Arming ISIS
The administration proposal would give the military “flexibility” to confront unforeseen circumstances, potentially by deploying Special Forces in the region. But it would limit the mission to three years and would not authorize “enduring offensive ground combat operations.”
But rather than roll up their sleeves and debate and vote on the president’s request for new military authorization, Republican leaders have effectively shelved the issue and moved on to other things, such as rewriting the rules for NSA spying on Americans’ phone calls and providing Obama with fast track authority to negotiate a new trade pact with Asian countries.
With many conservative Republicans including Sens. John McCain of Arizona and Lindsey Graham of South Carolina complaining that the president’s strategy for defeating ISIS woefully inadequate and some Democrats worried that it goes too far in committing U.S. troops and resources to a no-win situation in the Middle East, Senate Foreign Relations Committee Chair Bob Corker (R-TN) said recently he had no incentive to take up the issue in his committee.
Related: Why Congress Should Simply Bag the War Powers Debate
Frankly speaking, this is unacceptable,” McGovern, a member of the House Rules Committee, said on the House floor today, adding that if the Congress “doesn’t have the stomach” to authorize the war it should vote to bring U.S. forces home, according to Politico. McGovern introduced a bipartisan resolution that would require full debate within 15 days on whether U.S. troops should withdraw from Iraq and Syria. His bipartisan resolution is co-sponsored by Reps. Walter Jones (R-NC) and Barbara Lee (D-CA).
“This House appears to have no problem sending our uniformed men and women into harm’s way,” McGovern said in prepared remarks. “It appears to have no problem spending billions of dollars for the arms, equipment and airpower to carry out these wars. But it just can’t bring itself to step up to the plate and take responsibility for these wars.”
Chart of the Day: SALT in the GOP’s Wounds

The stark and growing divide between urban/suburban and rural districts was one big story in this year’s election results, with Democrats gaining seats in the House as a result of their success in suburban areas. The GOP tax law may have helped drive that trend, Yahoo Finance’s Brian Cheung notes.
The new tax law capped the amount of state and local tax deductions Americans can claim in their federal filings at $10,000. Congressional seats for nine of the top 25 districts where residents claim those SALT deductions were held by Republicans heading into Election Day. Six of the nine flipped to the Democrats in last week’s midterms.
Chart of the Day: Big Pharma's Big Profits
Ten companies, including nine pharmaceutical giants, accounted for half of the health care industry's $50 billion in worldwide profits in the third quarter of 2018, according to an analysis by Axios’s Bob Herman. Drug companies generated 23 percent of the industry’s $636 billion in revenue — and 63 percent of the total profits. “Americans spend a lot more money on hospital and physician care than prescription drugs, but pharmaceutical companies pocket a lot more than other parts of the industry,” Herman writes.
Chart of the Day: Infrastructure Spending Over 60 Years

Federal, state and local governments spent about $441 billion on infrastructure in 2017, with the money going toward highways, mass transit and rail, aviation, water transportation, water resources and water utilities. Measured as a percentage of GDP, total spending is a bit lower than it was 50 years ago. For more details, see this new report from the Congressional Budget Office.
Number of the Day: $3.3 Billion

The GOP tax cuts have provided a significant earnings boost for the big U.S. banks so far this year. Changes in the tax code “saved the nation’s six biggest banks $3.3 billion in the third quarter alone,” according to a Bloomberg report Thursday. The data is drawn from earnings reports from Bank of America, Citigroup, Goldman Sachs, JPMorgan Chase, Morgan Stanley and Wells Fargo.
Clarifying the Drop in Obamacare Premiums

We told you Thursday about the Trump administration’s announcement that average premiums for benchmark Obamacare plans will fall 1.5 percent next year, but analyst Charles Gaba says the story is a bit more complicated. According to Gaba’s calculations, average premiums for all individual health plans will rise next year by 3.1 percent.
The difference between the two figures is produced by two very different datasets. The Trump administration included only the second-lowest-cost Silver plans in 39 states in its analysis, while Gaba examined all individual plans sold in all 50 states.